Literature DB >> 3121349

Renal haemodynamics and sodium handling after hyperoncotic albumin infusion in sodium-restricted normal man.

W H Boer1, H A Koomans, E J Dorhout Mees.   

Abstract

The effect of plasma volume expansion with hyperoncotic albumin (HA) on renal haemodynamics and segmental tubular sodium (Na) handling was studied in eight water-loaded normal men. Clearance studies were performed before, during and after a 60-min infusion of 300 ml 20% HA. Sodium intake was restricted (20 mmol day-1) to mimic clinical conditions of relative hypovolaemia in which HA is often applied. Plasma volume rose by 740 +/- 160 ml after infusion and colloid oncotic pressure (COP) by 3.6 +/- 1.3 mm Hg. No natriuresis was induced. In fact, Na output fell from 43 +/- 29 to 28 +/- 25 mumol min-1 during infusion, returning to 41 +/- 36 mumol min-1 afterwards. Corresponding clearances of inulin were 121 +/- 19, 110 +/- 19 and 117 +/- 21 ml min-1 and of p-aminohippurate (CPAH) 602 +/- 87, 637 +/- 100 and 751 +/- 148 ml min-1. Fractional reabsorption of sodium in the proximal tubules (FPRNa), assessed from maximal free-water and lithium clearance, rose consistently during infusion but diverging patterns (further rise, no change or fall) were seen afterwards. Fractional distal reabsorption remained unchanged both during and after HA infusion. Changes in plasma volume and CPAH in the post-infusion period were correlated. These results indicate that, despite considerable plasma volume expansion, HA infusion does not enhance Na excretion in Na-restricted subjects. This is mainly due to elevation of plasma COP, which reduces glomerular filtration and enhances proximal reabsorption.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3121349     DOI: 10.1111/j.1365-2362.1987.tb01140.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  5 in total

1.  Hyperoncotic colloids in shock and risk of renal injury: enough evidence for a banning order?

Authors:  Patrick M Honore; Olivier Joannes-Boyau; Willem Boer
Journal:  Intensive Care Med       Date:  2008-08-07       Impact factor: 17.440

2.  Haemodynamic, renal sodium handling, and neurohormonal effects of acute administration of low dose losartan, an angiotensin II receptor antagonist, in preascitic cirrhosis.

Authors:  N Girgrah; P Liu; J Collier; L Blendis; F Wong
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

3.  Randomized cross-over trial comparing albumin and frusemide infusions in nephrotic syndrome.

Authors:  Rajmohan Dharmaraj; Pankaj Hari; Arvind Bagga
Journal:  Pediatr Nephrol       Date:  2009-01-14       Impact factor: 3.714

4.  The risk associated with hyperoncotic colloids in patients with shock.

Authors:  Frédérique Schortgen; Emmanuelle Girou; Nicolas Deye; Laurent Brochard
Journal:  Intensive Care Med       Date:  2008-08-07       Impact factor: 17.440

5.  Hyperoncotic Albumin Solution in Continuous Renal Replacement Therapy Patients.

Authors:  Zachary O'Brien; Mark Finnis; Martin Gallagher; Rinaldo Bellomo
Journal:  Blood Purif       Date:  2021-08-12       Impact factor: 3.348

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.